The use and availability of over-the-counter (OTC) medication is incre
asing. Although regulatory agencies take care to assure than nonprescr
iption medications are safe and effective, these drugs still have the
potential to have clinically significant interactions with prescriptio
n medicines, The major classes of OTC medication to be considered in t
his light include antacids, histamine H-2 receptor antagonists, NSAIDs
, cough and cold preparations and the antiasthma products. Healthcare
providers and patients/consumers should be educated regarding possible
drug interactions, patient drug regimens should be simplified where p
ossible, and all therapeutic failures and adverse reactions should be
investigated with regard to the potential contribution of OTC drug pro
ducts, Regulatory agencies and pharmaceutical manufacturers should ens
ure that nonprescription drug labelling is complete and intelligible t
o meet these objectives, Consideration should be given to improving th
e postmarketing surveillance of OTC medications.